跳转至内容
Merck
CN

G003762

HPLC Analysis of Piroxicam and 2-Aminopyridine in Urine on Discovery® HS F5 after SPE using Discovery® DSC-MCAX

application for SPE, application for HPLC

登录查看公司和协议定价

技术

HPLC: suitable
solid phase extraction (SPE): suitable

试验参数

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: human urine spiked with piroxicam (4 μg/mL) and 2-aminopyridine (10 μg/mL)
SPE tube/cartridge: Discovery DSC-MCAX, 100 mg/3 mL (52783-U)
condition: 1 mL methanol; 1 mL 10 mM potassium phosphate, pH 3
sample addition: 1 mL
washing: 1 mL 10 mM potassium phosphate, pH 3; 1 mL methanol
elution: 1 mL 5% ammonium hydroxide in methanol
eluate post-treatment: evaporate to dryness with nitrogen at room temperature, reconstitute in 1 mL mobile phase
column: Discovery HS F5, 15 cm x 4.6 mm I.D., 5 μm particles (567516-U)
mobile phase: [A] 10 mM potassium phosphate, pH 6: [B] acetonitrile (85:15, A:B)
flow rate: 2 mL/min
column temp.: 25 °C
detector: UV, 220 nm
injection: 10 μL

适用性

application for HPLC
application for SPE

应用

clinical

应用

Sample Pre-Treatment:
Piroxicam and 2-aminopyridine (piroxicam′s polar metabolite) was spiked into human urine at the levels of 4 and 10 μg/mL, respectively. The urine sample was diluted 1:1 with 10 mM potassium phosphate, pH 3.

法律信息

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门